Bezmialem Vakif University
Istanbul, Fatih, 34093, Turkey (Türkiye)
NCT Number: NCT04152746
Periostin is a matricellular protein that has been shown to be a marker of Type 2 inflammation associated with airway eosinophilia. Matricellular proteins are highly expressed at sites of injury or inflammation. Periostin involves tissue fibrosis and remodeling in the nasal mucosa in some of the otolaryngologic diseases. The up-regulation of periostin expression has been shown in allergic rhinitis, chronic rhinosinusitis with nasal polyps , and aspirin intolerant asthma. In the light of these findings the investigators aimed to evaluate the relation between adenoid hypertrophy and periostin levels.
Looking for future studies?
Notify Me2 year–12 year
All sexes
Observational
Istanbul, Fatih, 34093, Turkey (Türkiye)
A total of 40 patients-age ranged between 2 and 12 years- were planned to enroll in the study prospectively. Patients that were scheduled to undergo adenoidectomy were included in the study group (adenoid group). The control group comprised of 20 healthy children who had previously been treated for anemia in the out-patient clinic of the Pediatrics Department and were clinically healthy with normal complete blood cell counts at their follow-up visits.
Serum samples were obtained from the two groups. The samples were centrifuged at 1500 g for 5 minute and stored in -80 oC for later analysis of periostin levels. Adenoid tissue and normal mucosal tissue samples were obtained from the adenoidectomy patients and stored in -80 oC for later homogenization and measurement of periostin levels.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
(for adenoid group):
Exclusion criteria
(for control group):
The serum periostin levels were planned to compare between the serum samples that were obtained from the two groups. The evaluation of the periostin levels of adenoid tissue and normal healthy mucosa were also planned.
Time frame: 1 month
Serum periostin levels of the adenoid group and control group will be compared.
Time frame: 1 month
Periostin levels of the adenoid tissue and normal mucosal healthy tissue will be compared.
Bezmialem Vakif University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06841432
Adenoid Hypertrophy, Adenoidectomy
Asyut, Egypt
View Trial DetailsNCT03902314
Adenoid Hypertrophy, Children, Only
Providence, Rhode Island, United States
View Trial DetailsNCT03714919
Adenoid Hypertrophy
Columbus, Ohio, United States
View Trial DetailsNCT03677453
Adenoid Hypertrophy, Congenital Abnormalities
Columbus, Ohio, United States
View Trial Details